These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37270496)

  • 1. The pretherapeutic systemic inflammation score is a prognostic predictor for elderly patients with oesophageal cancer: a case control study.
    Huang C; Wang M; Chen L; Wang H; Huang D; Shi J; Zhang W; Tian Y; Zhu Y
    BMC Cancer; 2023 Jun; 23(1):505. PubMed ID: 37270496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative systemic inflammation score (SIS) is superior to neutrophil to lymphocyte ratio (NLR) as a predicting indicator in patients with esophageal squamous cell carcinoma.
    Fu X; Li T; Dai Y; Li J
    BMC Cancer; 2019 Jul; 19(1):721. PubMed ID: 31331297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel nomograms predicting the survival of patients with nonsurgical thoracic esophageal squamous cell carcinoma treated with IMRT: A retrospective analysis.
    Du X; Dong J; Yan K; Wang X; Shen W; Zhu S
    Medicine (Baltimore); 2022 Oct; 101(40):e30305. PubMed ID: 36221349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relationship between preoperative inflammatory indexes and prognosis of patients with rectal cancer and establishment of prognostic nomogram prediction model].
    Zhang L; Shi FY; Qin Q; Liu GX; Zhang HW; Yan J; Tan M; Wang LZ; Xue D; Hu CH; Zhang Z; She JJ
    Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):402-409. PubMed ID: 35615796
    [No Abstract]   [Full Text] [Related]  

  • 5. Systemic Immune-Inflammatory Index, Tumor-Infiltrating Lymphocytes, and Clinical Outcomes in Esophageal Squamous Cell Carcinoma Receiving Concurrent Chemoradiotherapy.
    Yang J; Zheng J; Qiu J; Zhang M; Liu L; Wang Z; Zheng Q; Liu Y; Chen M; Li J
    J Immunol Res; 2023; 2023():4275998. PubMed ID: 37228442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of lymphocyte-to-monocyte ratio (LMR) and neutrophil-to-lymphocyte ratio (NLR) in patients with oesophageal cancer undergoing concurrent chemoradiotherapy.
    Li KJ; Xia XF; Su M; Zhang H; Chen WH; Zou CL
    BMC Cancer; 2019 Oct; 19(1):1004. PubMed ID: 31655563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel inflammation-based prognostic index for patients with esophageal squamous cell carcinoma: Neutrophil lymphocyte ratio/prealbumin ratio.
    Lv Y; Zhang J; Liu Z; Tian Y; Liu F
    Medicine (Baltimore); 2019 Feb; 98(7):e14562. PubMed ID: 30762804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Albumin-Derived NLR Score is a Novel Prognostic Marker for Esophageal Squamous Cell Carcinoma.
    Abe T; Oshikiri T; Goto H; Kato T; Horikawa M; Sawada R; Harada H; Urakawa N; Hasegawa H; Kanaji S; Yamashita K; Matsuda T; Kakeji Y
    Ann Surg Oncol; 2022 Apr; 29(4):2663-2671. PubMed ID: 34807322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The predictive and prognostic role of a novel ADS score in esophageal squamous cell carcinoma patients undergoing esophagectomy.
    Gao QF; Qiu JC; Huang XH; Xu YM; Li SQ; Sun F; Zhang J; Yang WM; Min QH; Jiang YH; Chen QG; Zhang L; Wang XZ; Ying HQ
    Cancer Cell Int; 2018; 18():153. PubMed ID: 30305803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of preoperative lymphocyte-monocyte ratio in patients with resectable esophageal squamous cell carcinoma.
    Han LH; Jia YB; Song QX; Wang JB; Wang NN; Cheng YF
    Asian Pac J Cancer Prev; 2015; 16(6):2245-50. PubMed ID: 25824745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
    Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
    J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Value of the Systemic Immune-Inflammation Index in Predicting Survival Outcomes in Patients with Brain Metastases of Non-Small-Cell Lung Cancer Treated with Stereotactic Radiotherapy.
    Zhang Y; Chen Z; Jin F; Guo D; Chen Q; Liu Z; Ji S; Gao G
    Mediators Inflamm; 2021; 2021():2910892. PubMed ID: 34744510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical utility of the systemic immune-inflammation index for predicting survival in esophageal squamous cell carcinoma after radical radiotherapy.
    Wang Y; Lyu J; Jia H; Liang L; Xiao L; Liu Y; Liu X; Li K; Chen T; Zhang R; Zhang H; Tang C; Li T
    Future Oncol; 2021 Jul; 17(20):2647-2657. PubMed ID: 34008415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study on the prognostic influencing factors of esophageal squamous cell carcinoma and the predictive value of inflammatory reaction indexes on its postoperative recurrence].
    Wang X; Wang Z; Lu WL; Zhao GF
    Zhonghua Zhong Liu Za Zhi; 2023 Feb; 45(2):160-164. PubMed ID: 36781237
    [No Abstract]   [Full Text] [Related]  

  • 15. The predictive value of a preoperative systemic immune-inflammation index and prognostic nutritional index in patients with esophageal squamous cell carcinoma.
    Zhang H; Shang X; Ren P; Gong L; Ahmed A; Ma Z; Ma R; Wu X; Xiao X; Jiang H; Tang P; Yu Z
    J Cell Physiol; 2019 Feb; 234(2):1794-1802. PubMed ID: 30070689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A nomogram to predict short-term outcome of radiotherapy or chemoradiotherapy based on pre/post-treatment inflammatory biomarkers and their dynamic changes in esophageal squamous cell carcinoma.
    Liang S; Li C; Gao Z; Li J; Zhao H; Yu J; Meng X
    Int Immunopharmacol; 2021 Jan; 90():107178. PubMed ID: 33218939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pretreatment Controlling Nutritional Status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: results from a retrospective study.
    Toyokawa T; Kubo N; Tamura T; Sakurai K; Amano R; Tanaka H; Muguruma K; Yashiro M; Hirakawa K; Ohira M
    BMC Cancer; 2016 Sep; 16(1):722. PubMed ID: 27599460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of preoperative platelet-lymphocyte and neutrophil-lymphocyte ratio in patients undergoing surgery for esophageal squamous cell cancer.
    Xie X; Luo KJ; Hu Y; Wang JY; Chen J
    Dis Esophagus; 2016 Jan; 29(1):79-85. PubMed ID: 25410116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nomogram based on hematological markers to predict radiosensitivity in patients with esophageal squamous cell carcinoma.
    Sun L; Wei P; Ge S; Zheng J; Ye S; Zhang Y
    Medicine (Baltimore); 2023 Mar; 102(11):e33282. PubMed ID: 36930089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of platelet-to-albumin ratio in patients with esophageal squamous cell carcinoma receiving definitive radiotherapy.
    Huang Z; Zheng Q; Yu Y; Zheng H; Wu Y; Wang Z; Liu L; Zhang M; Liu T; Li H; Li J
    Sci Rep; 2022 Mar; 12(1):3535. PubMed ID: 35241740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.